The American Society for Pharmacy Law (ASPL) is the organization of attorneys, pharmacists, pharmacist-attorneys and students of pharmacy or law who are interested in the law as it applies to pharmacy, pharmacists, wholesalers, manufacturers, state and federal government and other interested parties.

ASPL is a nonprofit organization with the purposes of:

  • Furthering knowledge in the law related to pharmacists, pharmacies, the provision of pharmaceutical care, the manufacturing and distribution of drugs, and other food, drug, and medical device policy issues;
  • Communicating accurate legal educational information; and
  • Providing educational opportunities for pharmacists, attorneys, and others who are interested in pharmacy law

 

ASPL Programs & Services

Annual Educational Programs

 

Breaking Legal News and Regular Legal Updates (Must be an ASPL member to access.) JOIN NOW

  • Rx Ipsa Loquitur
  • PHARMA-LAW E-News

 

Connect with Legal Resources

 


Save the DATE November 14-17, 2013

 
ASPL Developments in Pharmacy Law Seminar XXIV

click here

 

---NEWS---

 May 13, 2013

FRAUD, WASTE & ABUSE
Ranbaxy pleads guilty to multiple felony charges and agrees to pay $500 million in settlement over adulterated drugs
The Department of Justice announced on May 13 that Ranbaxy USA Inc., a subsidiary of India’s generic manufacturer, Ranbaxy Laboratories Ltd., has pleaded guilty to 3 felony violations of the FDCA and 4 felony counts of “knowingly making false statements to the FDA.” The charges arise from the distribution and sale of batches of isotretinoin, gabapentin, and ciprofloxacin in 2005 and 2006 that were manufactured in India under conditions that rendered them adulterated.  


Read More